文献速递产科

血清糖基化纤连蛋白预测新发高血压孕妇近期子痫前期

Prediction using serum glycosylated fibronectin of imminent pre-eclampsia in women with new-onset hypertension.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-01-01

该前瞻性观察研究纳入409例24-41周妊娠新发高血压单胎孕妇,比较血清糖基化纤连蛋白(GlyFn)、胎盘生长因子(PlGF)及sFlt-1/PlGF比值对2周内因子痫前期(PE)分娩的预测效能。结果显示GlyFn与sFlt-1/PlGF及PlGF预测效能相似,但所有检测预测效能相对较差。

要点

  • GlyFn预测2周内因PE分娩的检出率为62.4%,与sFlt-1/PlGF相同,PlGF为60.2%。
  • 以sFlt-1/PlGF比值>85为参照,筛选阳性率46.2%时GlyFn切点为510 µg/mL,PlGF为75 pg/mL。
  • ≥38周妊娠时三种方法预测效能均较差,筛选阳性率40-50%时检出率仅47-63%。

核心结论

  • 在新发高血压孕妇中,血清GlyFn对2周内因PE分娩的预测效能与PlGF及sFlt-1/PlGF比值相似,但GlyFn可能为优选因为它是快速即时检验。
  • 然而所有检测的预测效能相对较差。

研究设计与样本

  • 前瞻性观察研究,纳入409例24-41周妊娠新发高血压单胎孕妇。
  • 比较血清GlyFn、PlGF及sFlt-1/PlGF比值对2周内因PE分娩的预测效能,并依据入组时孕周进行亚组分析。

主要发现

  • 2周内因PE分娩发生93例(22.7%)。
  • sFlt-1/PlGF比值>85的筛选阳性率为46.2%。
  • 对应筛选阳性率46.2%的切点:PlGF为75 pg/mL,GlyFn为510 µg/mL。
  • 2周内因PE分娩的总体检出率:GlyFn和sFlt-1/PlGF均为62.4%(95% CI,51.7-72.2%),PlGF为60.2%(95% CI,49.5-70.2%)。
  • 在<34周入组且2周内因PE分娩的所有孕妇及<38周入组者中约60-70%,GlyFn和sFlt-1/PlGF升高而PlGF降低,但这些检测的筛选阳性率非常高,约45%。

关键数值与推荐

  • 本研究平台推荐用于预测PE的sFlt-1/PlGF比值切点为85。
  • GlyFn和PlGF的适宜切点设定为达到与sFlt-1/PlGF比值>85相同的筛选阳性率。

临床怎么用

  • 作者认为GlyFn可能为优选选项,因为它是快速即时检验。
  • 作者指出所有检测的预测效能相对较差。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the predictive performance for delivery with pre-eclampsia (PE) within 2 weeks after assessment in women with new-onset hypertension at 24-41 weeks' gestation between serum glycosylated fibronectin (GlyFn) concentration, serum placental growth factor (PlGF) concentration and soluble fms-like tyrosine kinase-1 (sFlt-1) to PlGF concentration ratio. METHODS: This was a prospective observational study of 409 women with a singleton pregnancy presenting at 24-41 weeks' gestation with new-onset hypertension. The recommended cut-off for sFlt-1/PlGF ratio for the prediction of PE in the platform used in this study is 85; the appropriate cut-offs for GlyFn and PlGF were determined to achieve the same screen-positive rate as that of sFlt-1/PlGF ratio > 85. We then compared the predictive performance for delivery with PE within 2 weeks after presentation between GlyFn, PlGF and sFlt-1/PlGF, both overall and in subgroups according to gestational age at presentation. RESULTS: Delivery with PE within 2 weeks occurred in 93 (22.7%) cases. The screen-positive rate for sFlt-1/PlGF ratio > 85 was 46.2%. The cut-off corresponding to a screen-positive rate of 46.2% was 75 pg/mL for PlGF and 510 µg/mL for GlyFn. The overall detection rate for delivery with PE within 2 weeks after presentation was 62.4% (95% CI, 51.7-72.2%) for GlyFn and sFlt-1/PlGF and 60.2% (95% CI, 49.5-70.2%) for PlGF. In all women who delivered with PE within 2 weeks after presentation at < 34 weeks' gestation and in about 60-70% of those presenting at < 38 weeks, GlyFn and sFlt-1/PlGF were increased and PlGF was reduced. However, the screen-positive rate for these tests was very high at about 45%. The predictive performance for delivery with PE within 2 weeks after presentation at ≥ 38 weeks' gestation was poorer for all three methods of screening, with detection rates of 47-63% at screen-positive rates of 40-50%. CONCLUSIONS: In women with new-onset hypertension, the predictive performance for delivery with PE within 2 weeks after presentation for serum GlyFn is similar to that of PlGF and the sFlt-1/PlGF ratio, but GlyFn may be the preferred option because it is a rapid point-of-care test. However, the predictive performance for all tests is relatively poor. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Sokratous N, Bednorz M, Wright A, et al. Prediction using serum glycosylated fibronectin of imminent pre-eclampsia in women with new-onset hypertension. Ultrasound Obstet Gynecol. 2023. PMID: 37606310. doi:10.1002/uog.27458

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。